Preemptive Tecovirimat Use in an Active Duty Service Member Who Presented With Acute Myeloid Leukemia After Smallpox Vaccination
David A Lindholm(Uniformed Services University of the Health Sciences), Jason F. Okulicz(Gilead Sciences (United States)), Jay R Montgomery(Defense Health Agency), Patricia Yu(Centers for Disease Control and Prevention), Yon Yu(Department of Human Services), Raymond Fisher(Brooke Army Medical Center), Whitni Davidson, Brett W. Petersen(Centers for Disease Control and Prevention), Jillybeth Burgado, Kimberly Wilkins
Cited by 39
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Monkeypox Outbreak — Nine States, May 2022
|MMWR Morbidity and Mortality Weekly Report|2022|309
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021
|MMWR Morbidity and Mortality Weekly Report|2022|277